Big Data, Modern Alkame, smart drugs, nootropics
February 5, 2016 Podcast, Smart Drugs No Comments

Episode 114

In episode #114, Jesse speaks with Garrett Ruhland, CEO and co-founder of Modern AlkaMe, an online service aiming to help people navigate the nootropics landscape with personalized neuroscience info gleaned from machine learning and “Big Data.”

Ruhland’s first foray into the world of retail nootropics was on the manufacturing and sales side — but he spotted a problem it seemed the industry hadn’t solved yet: Beginners wanting to try nootropics were often overwhelmed by the fragmented info available on the web.  Every supplement sounded like it might be a good idea on its own, but how do all theses things interact with one another?

Many people hesitated to take the first step because they were concerned about contraindications with other supplements, or with prescription medications in their health regimen.

Many also wondered how to tell for sure if a supplement was really having an effect.

The wheels in Ruhland’s head started turning…

Modern AlkaMe’s “Low-Effort Biohacking”

We probably all know some people who are willing to keep detailed, meticulous records of their day-in, day-out performance — and all their daily inputs and results — to see what’s working for them.

But let’s face it, these some people are not most people.  They’re the oddballs.

(Maybe you’re even one of them.  If so, kudos.)

But even for the hardest of the biohacking hardcore, the “n=1” experiments and continual tracking and stacking can become wearisome.  And perhaps cognitive biases are still preventing these folks from finding the optimal stack for their needs?

Ruhland wondered: Is there a scalable way for people to benefit from others’ experience without having to comb through Reddit threads and best-guess which writers’ stories applied to them?  His search for a solution led to Modern AlkaMe.

Placebo-controlled studies at home?

Probably the coolest offering from Modern AlkaMe is their soon-to-launch ability for customers to give stacks the “Pepsi Challenge” and see what they prefer — without actually knowing what they’re taking.  Placebo effects (as we’ve discussed before) are a powerful and potentially confounding factor in determining what a supplement is or isn’t doing.  But, Modern AlkaMe claims to have an effective strategy for how to do a controlled study on yourself, over the course of a month, and without much effort.

Listen in to hear all the details of the Modern AlkaMe story, and their plans to crowdsource ever more data to further refine best practices in stack design.

PS:  Make tracking the latest neuroscience news easier by signing up for our newsletter, the Brain Breakfast – delivered weekly from Jesse’s brain to your inbox.

Written by Michelle Silbernagel
Michelle, a deep rabbit hole diver, is a quintessential seeker of knowledge and an avid content consumer. She is devoted to optimizing health, particularly brain health, and believes that everything is connected – from the thoughts we think to the food we eat and the moves we make. At Smart Drug Smarts she switch-hits on everything from industry research to article writing to ideological cheerleading in the wider media world. Personal Motto: Life is an n=1 experiment.
Affiliate Disclosure
This website contains affiliate links, which means Jesse may receive a percentage of any product or service you purchase using the links in the articles or ads.  You will pay the same price for all products and services, and your purchase helps support Smart Drug Smarts' ongoing publications.  Thanks for your support!